Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Head & Neck 1

Conditions

Stomatitis 2Mucositis 2Pain, Postoperative 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anastomotic Leak 1

Interventions

Cisplatin 4angiotensin I (1-7) 3Radiotherapy 3Radiation 3Injections 3Water 2RRx-001 2Interleukin 1 Receptor Antagonist Protein 2Drug Therapy 2Amifostine 2tempol 1peppermint oil 1pegfilgrastim 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1glucarpidase 1fish oil triglycerides 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vaccinium myrtillus extract 1Tramadol 1Therapeutics 1Surgical Procedures, Operative 1Sorbic Acid 1Sodium Bicarbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Mucositis × Water × Clear all
NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

NCT01898091 2017-03-06

OM

Medical University of South Carolina

Phase 2 Completed
50 enrolled 9 charts
Other

Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡